-
Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successor
Read more: Halozyme wins Munich PI against Merck’s Keytruda SC (subcutaneous immunotherapy); meanwhile, litigators await appointment of Judge Werner’s successorOn Thursday, Halozyme obtained a preliminary injunction against Merck’s Keytruda SC.
-
UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened since
Read more: UK consultation on SEP legislation closed two months ago, and they can already scrap their plans because of what has happened sinceThe UK government gave stakeholders 12 weeks to comment on its vision of global FRAND resolution, but the following month the landscape changed.
-
USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memoranda
Read more: USPTO Director Squires encourages fairer, more consistent patent eligibility in latest memorandaUSPTO Director John A. Squires reminds applicants and examiners that when used properly, Subject-Matter Eligibility Declarations can be effective, encouraging examiners not to reject patent applications too broadly.
-
Netflix now has exclusive merger talks with Warner Bros. Discovery despite Trump-aligned Paramount having raised antitrust concerns
Read more: Netflix now has exclusive merger talks with Warner Bros. Discovery despite Trump-aligned Paramount having raised antitrust concernsGiven the current wave of patent enforcement actions against video streamers, including Nokia v. Warner Bros. Discovery, we exceptionally share some thoughts on a proposed streaming merger with upstream implications for the video patent licensing market.
-
InterDigital’s jurisdictional challenge to Amazon’s UK claims heard by skeptical judge; Amazon rejects LJ Arnold’s arbitration idea
Read more: InterDigital’s jurisdictional challenge to Amazon’s UK claims heard by skeptical judge; Amazon rejects LJ Arnold’s arbitration ideaThe hurdle to get standalone FRAND claims in the UK dismissed for jurisdicitonal reasons appears to remain very high, if not insurmountable.
-
Delhi High Court allows Dr. Reddy’s to enter Indian semaglutide market in March 2026, dismisses Novo Nordisk appeal
Read more: Delhi High Court allows Dr. Reddy’s to enter Indian semaglutide market in March 2026, dismisses Novo Nordisk appealIn a landmark judgment, the Delhi High Court has ruled that Novo Nordisk failed to prove why it should be granted an interim injunction against Dr. Reddy’s, but has ordered the latter not to proceed with sales in Indian until the patent-in-suit expires on March 20, 2026.
-
Infineon handed preliminary win in ITC patent infringement dispute against Innoscience
Read more: Infineon handed preliminary win in ITC patent infringement dispute against InnoscienceThe United States International Trade Commission has issued a final initial determination finding that one of two gallium nitride patents that Infineon asserted against Chinese rival Innoscience has been infringed.
-
Podcast: interview with Avanci’s Laurie Fitzgerald on Avanci Vehicle expectations in 2026, women in leadership, China
Read more: Podcast: interview with Avanci’s Laurie Fitzgerald on Avanci Vehicle expectations in 2026, women in leadership, ChinaIn our latest podcast episode, ip fray interviewed Laurie Fitzgerald, President of Avanci Vehicle.
Follow Us
Latest Articles
- Judge Gilstrap finds Verizon reasonably expected not to get sued by Headwater (in which it invested), tosses $175M jury verdict
- CureVac sues Moderna in Delaware over Spikevax patents, seeking treble damages but no injunction
- Disney faces clear and present danger of UPC 11-country HEVC patent injunction in InterDigital case after May 5 & 6 hearing: court document
- IP Bridge’s Geely injunction stayed in Brazil; GWM proceedings show ongoing enforcement
- ECJ Advocate General says excipient label is binding for SPC purposes: Halozyme v. Czech IPO